Protective Effects of Herbacetin in Experimental Colitis: Targeting NF‐κB and NLRP3 Pathways
Drug Development Research · 2026
DOI: 10.1002/ddr.70195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, 2026. Verfasst von Yousra Bseiso und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology and Biotechnology, Faculty of Science, The Hashemite University, Zarqa, Jordan. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, NF-kappa B, Flavonoids, Colitis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at the Hashemite University, Zarqa, Jordan (Grant number: 31….
Abstract (Originalsprache)
Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD) resulting from a dysregulation of immune responses. Herbacetin, a flavonoid of natural origin, has been found to exert an anti‐inflammatory action, though its actions in experimental colitis are unknown. Colitis was induced in BALB/c mice with 2,4,6‐trinitrobenzenesulfonic acid (TNBS). Mice were administered with herbacetin (25, 50, 100 mg/kg) or sulfasalazine (100 mg/kg) orally for 7 days. The disease activity index (DAI), colon length, weight/length ratio, histopathology, MPO and NO contents, and inflammatory gene expression (NF‐κB, iNOS, COX‐2, NLRP3, IL‐1β, IL‐18) were evaluated. TNBS induced marked weight loss and increased DAI ( p < 0.01 vs. NC). Body weight ( p < 0.01) and DAI ( p < 0.01) were significantly ameliorated by herbacetin, especially at 50 and 100 mg/kg. TNBS significantly reduced the colon length ( p < 0.001) and increased the weight/length ratio ( p < 0.001), which were significantly counteracted by herbacetin ( p < 0.01–0.001). TNBS mice presented with mucosal injury and inflammatory infiltration were demonstrated by histopathology ( p < 0.001) and a dose‐dependent healing effect was observed in herbacetin‐treated mice. TNBS mice had higher levels of MPO and NO ( p < 0.001), which were significantly attenuated by herbacetin ( p < 0.01–0.001). Herbacetin decreased the mRNA expression levels of NF‐κB, iNOS, COX‐2, NLRP3, IL‐1β, and IL‐18 in a dose‐dependent ( p < 0.05–0.001). Herbacetin exerts a protective effect in colitis by suppressing neutrophil infiltration, oxidative stress, and NF‐κB–NLRP3‐mediated inflammation, highlighting the potential of herbacetin‐based treatment for UC and related inflammatory bowel diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology and Biotechnology, Faculty of Science, The Hashemite University, Zarqa, Jordan.
- Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
- Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan.
- Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan.
- Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pahrmacy, Jerash University, Jerash, Jordan.
- Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordan.
ORCID-Profile: Alaa A A Aljabali, Omar Gammoh, Abdelrahim Alqudah
Förderung
- The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at the Hashemite University, Zarqa, Jordan (Grant number: 31…
Zitieren
APA
Bseiso, Y., Alotaibi, B. S., Aljabali, A. A. A., Gammoh, O., Rabeh, M. E., Rabi, A. M., Qnais, E., & Alqudah, A. (2026). Protective Effects of Herbacetin in Experimental Colitis: Targeting NF‐κB and NLRP3 Pathways. Drug Development Research. https://doi.org/10.1002/ddr.70195
Vancouver
Bseiso Y, Alotaibi BS, Aljabali AAA, Gammoh O, Rabeh ME, Rabi AM, et al. Protective Effects of Herbacetin in Experimental Colitis: Targeting NF‐κB and NLRP3 Pathways. Drug Development Research. 2026. doi:10.1002/ddr.70195
BibTeX
@article{Bseiso2026,
author = {Bseiso, Yousra and Alotaibi, Badriyah S and Aljabali, Alaa A A and Gammoh, Omar and Rabeh, Mohammad E and Rabi, Ahmad M and Qnais, Esam and Alqudah, Abdelrahim},
title = {Protective Effects of Herbacetin in Experimental Colitis: Targeting NF‐κB and NLRP3 Pathways},
journal = {Drug Development Research},
year = {2026},
doi = {10.1002/ddr.70195}
}
EUVIMED